No connection

Search Results

Earnings Score 48 Bearish

Roche Q1 Revenue Slips Amid Currency Headwinds and Generic Competition

Apr 23, 2026 05:15 UTC
RHHBY, ROG.SW
Short term

Swiss pharmaceutical giant Roche reported a decline in first-quarter sales, missing analyst expectations. The drop was driven by a strong Swiss franc and increased competition for legacy drugs.

  • Q1 revenue dropped 5% to 14.7 billion Swiss francs
  • Results missed analyst forecasts of 15.1 billion francs
  • Constant currency growth remained positive at 6%
  • Sales pressured by Swiss franc appreciation
  • Increased competition for older medicines impacted top line

Roche Holding AG announced a 5% decline in first-quarter revenue, totaling 14.7 billion Swiss francs ($18.7 billion). The results fell short of the 15.1 billion francs anticipated by analysts, reflecting the ongoing challenges the company faces as its older portfolio loses market share to competitors. While reported figures showed a decline, the company noted a 6% growth rate when measured at constant currencies. This discrepancy highlights the significant impact of the Swiss franc's appreciation against the U.S. dollar, which eroded the reported value of international sales. Beyond currency volatility, the company is grappling with the rise of biosimilars and generic 'copycat' medicines. These competitors have targeted Roche's older pharmaceutical offerings, creating a drag on the top line that the company must offset through its newer pipeline developments. Market analysts will likely view these results as a reflection of the broader transition period for the pharmaceutical giant as it pivots away from legacy blockbusters toward next-generation therapies.

Sign up free to read the full analysis

Create a free account to unlock full AI-curated market articles, personalized alerts, and more.

Create Free Account Already have an account? Sign In
Share this article

Related Articles

Score 42

Sartorius Reports Mixed Q1 Results, Maintains 2026 Outlook

Apr 23, 06:23

Score 52 Bullish

Orange S.A. Lifts Full-Year Guidance Following Strong Q1 Growth

Apr 23, 06:22

Score 48 Bearish

Hyundai Motor Q1 Profits Slump Despite Revenue Growth

Apr 23, 06:05

Score 45 Bullish

Teck Resources Posts Strong Q1 Growth with 72% Revenue Surge

Apr 23, 06:05

Stay Ahead of the Markets

Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.

Get Started Free View Plans
Features Terminal AI Assistant Analysis Market News Pricing
Start Trading with AI Already have an account? Sign In
Home
Terminal
AI
Markets
Profile